Analysis of relationships between peptide/MHC structural features and naive T cell frequency in humans

Journal of Immunology

Volumn 193, Issue 12, 2014, Pages 5816-5826

  Reiser, Jean Baptiste ^a,b,c   Legoux, Franҫois ^d,f   Gras, Stéphanie ^a,b,c,g   Trudel, Eric ^a,b,c   Chouquet, Anne ^a,b,c   Léger, Alexandra ^d   Le Gorrec, Madalen ^a,b,c   Machillot, Paul ^a,b,c   Bonneville, Marc ^d   Saulquin, Xavier ^d,e   Housset, Dominique ^a,b,c  

^a UNIV GRENOBLE ALPES   (France)

^b INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^c CNRS   (France)

^d INSERM   (France)

^e UNIVERSITÉ DE NANTES   (France)

^f HARVARD MEDICAL SCHOOL   (United States)

^g MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; PEPTIDE; PEPTIDE DERIVATIVE; SOLVENT; T LYMPHOCYTE RECEPTOR; EPITOPE; HLA A2 ANTIGEN; HLA ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN BINDING; TUMOR ANTIGEN; VIRUS ANTIGEN;

ANTIGEN STRUCTURE; ARTICLE; CELL MOTILITY; CELL SPECIFICITY; CELL SURFACE; CONTROLLED STUDY; GERM LINE; HUMAN; HUMAN CELL; MOLECULAR DOCKING; NONHUMAN; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; IMMUNOLOGY; METABOLISM; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; ANTIGENS, VIRAL; EPITOPES, T-LYMPHOCYTE; HLA ANTIGENS; HLA-A2 ANTIGEN; HUMANS; MODELS, MOLECULAR; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; RECEPTORS, ANTIGEN, T-CELL; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTE SUBSETS;

EID: 84916919273     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303084     Document Type: Article

References (50)

1. Garboczi, D. N., P. Ghosh, U. Utz, Q. R. Fan, W. E. Biddison, and D. C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384: 134-141.
2. Garcia, K. C., M. Degano, R. L. Stanfield, A. Brunmark, M. R. Jackson, P. A. Peterson, L. Teyton, and I. A. Wilson. 1996. An αβ T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 274: 209-219.
3. Tynan, F. E., S. R. Burrows, A. M. Buckle, C. S. Clements, N. A. Borg, J. J. Miles, T. Beddoe, J. C. Whisstock, M. C. Wilce, S. L. Silins, et al. 2005. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Nat. Immunol. 6: 1114-1122.
4. Liu, Y. C., J. J. Miles, M. A. Neller, E. Gostick, D. A. Price, A. W. Purcell, J. McCluskey, S. R. Burrows, J. Rossjohn, and S. Gras. 2013. Highly divergent T-cell receptor binding modes underlie specific recognition of a bulged viral peptide bound to a human leukocyte antigen class I molecule. J. Biol. Chem. 288: 15442-15454.
5. Burrows, S. R., Z. Chen, J. K. Archbold, F. E. Tynan, T. Beddoe, L. Kjer-Nielsen, J. J. Miles, R. Khanna, D. J. Moss, Y. C. Liu, et al. 2010. Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability. Proc. Natl. Acad. Sci. USA 107: 10608-10613.
6. + T cell populations. Nat. Immunol. 6: 382-389.
7. Stewart-Jones, G. B., A. J. McMichael, J. I. Bell, D. I. Stuart, and E. Y. Jones. 2003. A structural basis for immunodominant human T cell receptor recognition. Nat. Immunol. 4: 657-663.
8. + T-cell repertoire selection in a persistent viral infection. Blood 111: 4283-4292.
9. + T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27: 203-213.
10. + T cell immunodominance. J. Immunol. 181: 2124-2133.
11. +T cell precursor frequency regulates primary and memory responses to infection. Immunity 28: 859-869.
12. La Gruta, N. L., W. T. Rothwell, T. Cukalac, N. G. Swan, S. A. Valkenburg, K. Kedzierska, P. G. Thomas, P. C. Doherty, and S. J. Turner. 2010. Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion. J. Clin. Invest. 120: 1885-1894.
13. + T-cells is not related to naive precursor frequency. Immunol. Lett. 149: 119-122.
14. Cukalac, T., J. Chadderton, W. Zeng, J. G. Cullen, W. T. Kan, P. C. Doherty, D. C. Jackson, S. J. Turner, and N. L. La Gruta. 2014. The influenza virus-specific CTL immunodominance hierarchy in mice is determined by the relative frequency of high-avidity T cells. J. Immunol. 192: 4061-4068.
15. + T cell responses. J. Exp. Med. 208: 81-90.
16. Stone, J. D., M. N. Artyomov, A. S. Chervin, A. K. Chakraborty, H. N. Eisen, and D. M. Kranz. 2011. Interaction of streptavidin-based peptide-MHC oligomers (tetramers) with cell-surface TCRs. J. Immunol. 187: 6281-6290.
17. Laugel, B., H. A. van den Berg, E. Gostick, D. K. Cole, L. Wooldridge, J. Boulter, A. Milicic, D. A. Price, and A. K. Sewell. 2007. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J. Biol. Chem. 282: 23799-23810.
18. Jenkins, M. K., and J. J. Moon. 2012. The role of naive T cell precursor frequency and recruitment in dictating immune response magnitude. J. Immunol. 188: 4135-4140.
19. Legoux, F., E. Debeaupuis, K. Echasserieau, H. De La Salle, X. Saulquin, and M. Bonneville. 2010. Impact of TCR reactivity and HLA phenotype on naive CD8 T cell frequency in humans. J. Immunol. 184: 6731-6738.
20. + T cells reveals conserved precursor frequencies. Blood 115: 3718-3725.
21. + T cell populations. J. Immunol. 185: 4705-4713.
22. Bodinier, M., M. A. Peyrat, C. Tournay, F. Davodeau, F. Romagne, M. Bonneville, and F. Lang. 2000. Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding. Nat. Med. 6: 707-710.
23. Garboczi, D. N., D. T. Hung, and D. C. Wiley. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89: 3429-3433.
24. Gras, S., X. Saulquin, J. B. Reiser, E. Debeaupuis, K. Echasserieau, A. Kissenpfennig, F. Legoux, A. Chouquet, M. Le Gorrec, P. Machillot, et al. 2009. Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope. J. Immunol. 183: 430-437.
25. Kabsch, W. 1993. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J. Appl. Cryst. 26: 795-800.
26. Navaza, J. 1994. AMoRe: an automated package for molecular replacement. Acta Crystallogr. A 50: 157-163.
27. Collaborative Computational Project, Number 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50: 760-763.
28. Emsley, P., and K. Cowtan. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60: 2126-2132.
29. + T cells in humans. J. Exp. Med. 196: 207-216.
30. Borbulevych, O. Y., F. K. Insaidoo, T. K. Baxter, D. J. Powell, Jr., L. A. Johnson, N. P. Restifo, and B. M. Baker. 2007. Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition. J. Mol. Biol. 372: 1123-1136.
31. Sliz, P., O. Michielin, J. C. Cerottini, I. Luescher, P. Romero, M. Karplus, and D. C. Wiley. 2001. Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes. J. Immunol. 167: 3276-3284.
32. Madden, D. R., D. N. Garboczi, and D. C. Wiley. 1993. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75: 693-708.
33. Ishizuka, J., G. B. Stewart-Jones, A. van der Merwe, J. I. Bell, A. J. McMichael, and E. Y. Jones. 2008. The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain. Immunity 28: 171-182.
34. Martinez-Hackert, E., N. Anikeeva, S. A. Kalams, B. D. Walker, W. A. Hendrickson, and Y. Sykulev. 2006. Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes. J. Biol. Chem. 281: 20205-20212.
35. Lee, J. K., G. Stewart-Jones, T. Dong, K. Harlos, K. Di Gleria, L. Dorrell, D. C. Douek, P. A. van der Merwe, E. Y. Jones, and A. J. McMichael. 2004. T cell cross-reactivity and conformational changes during TCR engagement. J. Exp. Med. 200: 1455-1466.
36. Spierings, E., S. Gras, J. B. Reiser, B. Mommaas, M. Almekinders, M. G. Kester, A. Chouquet, M. Le Gorrec, J. W. Drijfhout, F. Ossendorp, et al. 2009. Steric hindrance and fast dissociation explain the lack of immunogenicity of the minor histocompatibility HA-1Arg Null allele. J. Immunol. 182: 4809-4816.
37. Godet, Y., J. Desfranc¸ois, V. Vignard, D. Schadendorf, A. Khammari, B. Dreno, F. Jotereau, and N. Labarrière. 2010. Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy. Eur. J. Immunol. 40: 1786-1794.
38. Douat-Casassus, C., N. Marchand-Geneste, E. Diez, N. Gervois, F. Jotereau, and S. Quideau. 2007. Synthetic anticancer vaccine candidates: rational design of antigenic peptide mimetics that activate tumor-specific T-cells. J. Med. Chem. 50: 1598-1609.
39. Cole, D. K., F. Yuan, P. J. Rizkallah, J. J. Miles, E. Gostick, D. A. Price, G. F. Gao, B. K. Jakobsen, and A. K. Sewell. 2009. Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor. J. Biol. Chem. 284: 27281-27289.
40. Borbulevych, O. Y., S. M. Santhanagopolan, M. Hossain, and B. M. Baker. 2011. TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms. J. Immunol. 187: 2453-2463.
41. Garcia, K. C., M. Degano, L. R. Pease, M. Huang, P. A. Peterson, L. Teyton, and I. A. Wilson. 1998. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279: 1166-1172.
42. Kjer-Nielsen, L., C. S. Clements, A. W. Purcell, A. G. Brooks, J. C. Whisstock, S. R. Burrows, J. McCluskey, and J. Rossjohn. 2003. A structural basis for the selection of dominant αβ T cell receptors in antiviral immunity. Immunity 18: 53-64.
43. Reiser, J. B., C. Darnault, C. Grégoire, T. Mosser, G. Mazza, A. Kearney, P. A. van der Merwe, J. C. Fontecilla-Camps, D. Housset, and B. Malissen. 2003. CDR3 loop flexibility contributes to the degeneracy of TCR recognition. Nat. Immunol. 4: 241-247.
44. Reiser, J. B., C. Grégoire, C. Darnault, T. Mosser, A. Guimezanes, A. M. Schmitt-Verhulst, J. C. Fontecilla-Camps, G. Mazza, B. Malissen, and D. Housset. 2002. A T cell receptor CDR3β loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. Immunity 16: 345-354.
45. Tynan, F. E., H. H. Reid, L. Kjer-Nielsen, J. J. Miles, M. C. Wilce, L. Kostenko, N. A. Borg, N. A. Williamson, T. Beddoe, A. W. Purcell, et al. 2007. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat. Immunol. 8: 268-276.
46. Rudolph, M. G., R. L. Stanfield, and I. A. Wilson. 2006. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24: 419-466.
47. Gras, S., S. R. Burrows, S. J. Turner, A. K. Sewell, J. McCluskey, and J. Rossjohn. 2012. A structural voyage toward an understanding of the MHCI-restricted immune response: lessons learned and much to be learned. Immunol. Rev. 250: 61-81.
48. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. Melief, C. Oseroff, L. Yuan, J. Ruppert, et al. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153: 5586-5592.
49. Chen, W., L. C. Antón, J. R. Bennink, and J. W. Yewdell. 2000. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12: 83-93.
50. Holler, P. D., and D. M. Kranz. 2003. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity 18: 255-264.